November 3, 2025 
3 min read 
Hims & Hers Health (HIMS) is scheduled to report quarterly results on November 3rd after market close. Year-to-date the stock is higher by more than 80%, while trading over the past six months has shown limited directional progress as investors evaluate the sustainability of growth.
The company began with a focus on men's health and has since expanded its offerings into women's health. It has also entered international markets and rolled out multiple new products, including a move into weight loss treatments that materially contributed to recent revenue gains.
Per the most recent report, Hims & Hers serves about 2.4 million users. That scale places the firm in a higher-risk profile. The stock exhibits elevated sensitivity to market swings with a quoted Beta in the 1.85-2.10 range - roughly indicating moves about twice the index on days the market rises or falls.
Revenue growth was 69% in the prior year, aided by product expansion and international sales. Net margin reported at 8.45% and 7.8% in the first two quarters of this year, respectively. On a trailing twelve-month basis the company carries a price-to-earnings ratio of 55x, compared with an S&P 500 average near 30x.
Over recent trading ranges the share price has moved between lows of 25.00 and highs of 78.00, consistent with the elevated Beta and the stock's pronounced intraday and multi-day swings.
The incoming report is highlighted as a potential catalyst. Analysis emphasizes the need for sustained subscriber growth and continued execution on U.S. and international market expansion to maintain investor interest. Given the current revenue base and growth expectations, a significant shortfall versus projections could present material challenges for the company.
Market option pricing for $HIMS shows the November 7th expiration with implied volatility around 173%, which corresponds to an expected move of approximately (+/-) $7 from the underlying price by that expiration. The directional outcome will hinge on the earnings result and commentary provided on the call.
This material is provided for informational and educational purposes only and does not constitute financial advice. All investments carry risk, including the potential loss of capital.
